Philip Johnson to Retire as Lilly Treasurer

Sample article from our Health Care Sector

February 9, 2024 (press release) –

INDIANAPOLIS , Feb. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that after more than 28 years, Philip Johnson , group vice president and treasurer, will retire from the company at the end of February to pursue a new professional opportunity.

"Phil has had a meaningful impact on Lilly over the last 28 years," said Anat Ashkenazi , executive vice president and chief financial officer at Lilly . "Through his deep financial knowledge and understanding of the business, industry and stakeholders, Phil has played a key leadership role in the company and is well recognized for his commitment to Lilly 's purpose and the patients we serve. Additionally, he is known for his passion for talent development, having invested significant time mentoring and coaching colleagues across the globe."

Throughout his tenure, Johnson supported a variety of operations, including Lilly affiliates in Japan and Spain , global manufacturing and quality organizations, and business development activities. He led Lilly 's investor relations group for 11 years and was consistently named Top Investor Relations Officer by Institutional Investor. He has served as Lilly 's treasurer since 2018 and has led the company's efforts within the financial community to drive positive social and economic change for underrepresented groups.

Johnson's successor will be named at a future date.

About Lilly

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn. C-LLY

Lilly Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995), including related to leadership changes and Lilly 's strategy, and reflects Lilly 's current beliefs and expectations. There can be no assurance that the leadership changes will achieve Lilly 's objectives or that Lilly will execute its strategy as planned. For further discussion of risks and uncertainties relevant to Lilly 's business, please see Lilly 's most recent Forms 10-K and 10-Q filed with the U.S. Securities and Exchange Commission . Lilly undertakes no duty to update forward-looking statements.

Refer to:   Carrie Munk , munk_carrie@lilly.com, 317-416-2393

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/philip-johnson-to-retire-as-lilly-treasurer-302058585.html

SOURCE Eli Lilly and Company

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

More from our Health Care Sector Coverage
See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order health care sector coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.